Chennai Meenakshi Multispeciality Hospital Limited has appointed M. Karunakaran as an Additional Non-Executive Independent Director for a term of five consecutive years, effective August 7, 2026. The appointment was approved by the Board of Directors during a meeting held via video conference on August 7, 2026, from 12:30 PM to 1:45 PM IST. This decision strengthens the company’s governance framework by adding an experienced professional to the boardroom, subject to shareholder approval at the ensuing Annual General Meeting.

The Board also reconstituted three key committees consequent to Mr. Karunakaran’s appointment: the Audit Committee, the Nomination and Remuneration Committee, and the Stakeholders Relationship Committee. These changes ensure compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and enhance oversight mechanisms within the organization.

Appointment Details and Profile

M. Karunakaran, holding Director Identification Number (DIN) 11874200, brings extensive experience in banking, financial management, and corporate governance. He is a retired Chief Manager of Indian Overseas Bank and is currently a practicing Advocate enrolled with the Madras Bar Association. His background includes expertise in risk assessment, credit administration, and regulatory compliance.

The company affirmed that Mr. Karunakaran is not related to any existing Director or Key Managerial Personnel (KMP) and is not debarred from holding office by any order passed by SEBI or other authorities. The appointment aligns with Section 173(3) of the Companies Act, 2013, which allows for short-notice convening of board meetings with requisite consent from independent directors.

Committee Reconstitution

Following the appointment, the Board reshuffled its committees to incorporate Mr. Karunakaran into key oversight roles:

• Audit Committee: Mr. M. Karunakaran serves as Chairman, alongside members Mrs. Shama Dhilip (Independent Director) and Mrs. Jayanthi Radhakrishnan (Executive Director).
• Nomination and Remuneration Committee: Mrs. Shama Dhilip chairs this committee, with Mr. M. Karunakaran and Mr. Akash Prabhakar (Non-Executive Director) as members.
• Stakeholders Relationship Committee: Mr. M. Karunakaran chairs this committee, supported by Mrs. Shama Dhilip and Mr. Edward Prabhakar (Non-Executive Director).

These reconstituted structures aim to improve stakeholder engagement and ensure robust financial and operational oversight. The disclosures were made in compliance with Regulation 30 of the SEBI LODR Regulations, 2015, and relevant SEBI Master Circulars.

Governance Implications

The addition of an independent director with a strong banking and legal background enhances Chennai Meenakshi Multispeciality Hospital Limited’s ability to manage risks and maintain ethical standards. Independent directors play a critical role in protecting minority shareholder interests and providing objective guidance on strategic matters. This move underscores the company’s commitment to transparent and effective corporate governance.

Dr. Venkataraman Krishnamurthy has resigned as Chief Executive Officer of chennai meenakshi multispeciality effective from the close of business hours on June 15, 2026, due to personal reasons. The company disclosed that there are no other material reasons for his departure. The resignation was intimated to BSE pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

The company submitted the necessary disclosures to the stock exchange, including the resignation letter dated June 15, 2026. The communication was signed by M. S. Anantha Lakshmi, Company Secretary and Compliance Officer.

In his resignation letter addressed to the Board of Directors, Dr. Krishnamurthy expressed gratitude to the Board, promoters, and the management team for their support during his tenure. He confirmed that he would ensure a smooth transition of his responsibilities before his exit.